Early norepinephrine for low blood pressure in sepsis
Part of Infections clinical trials.
This trial tests whether starting norepinephrine early can improve outcomes for adults with sepsis who have low blood pressure. It may help stabilize circulation sooner and reduce complications from severe infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- You (or your legally authorized representative) can sign informed consent in writing
- Have a diagnosis of sepsis based on Sepsis-3 definitions
- Have mean arterial pressure (MAP) under 65 mmHg
- Not be in septic shock before randomization (as defined by the trial’s criteria)
- Not be pregnant and not need immediate surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This trial tests whether giving a second medicine called vasopressin early (along with norepinephrine) helps people with sepsis and low blood pressure better than waiting to use vasopressin only if norepinephrine doesn't work. It may improve blood pressure control and reduce the need for strong medicines.
This trial tests whether giving a medicine called norepinephrine before anesthesia can help stabilize blood pressure in patients with sepsis who are having surgery. It aims to reduce complications during and after the operation.
This study compares two medicines—norepinephrine and angiotensin II—to see which one works better at raising blood pressure in people with septic shock (a severe infection that causes dangerously low blood pressure). It aims to find out which approach helps patients recover better.
This trial tests a drug called angiotensin II for people in the emergency room who need a specific dose of norepinephrine (a medicine to raise blood pressure) and are also getting antibiotics. The goal is to see if giving angiotensin II early can help stabilize blood pressure.
Hear when a new Sepsis, Severe trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.